Premium
Iron accelerates the conversion of dopamine‐oxidized intermediates into melanin and provides protection in SH‐SY5Y cells
Author(s) -
Izumi Yasuhiko,
Sawada Hideyuki,
Yamamoto Noriyuki,
Kume Toshiaki,
Katsuki Hiroshi,
Shimohama Shun,
Akaike Akinori
Publication year - 2005
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.20595
Subject(s) - dopamine , dopaminergic , chemistry , substantia nigra , melanin , sh sy5y , catalase , reactive oxygen species , oxidative stress , biochemistry , glutathione , biology , cell culture , enzyme , endocrinology , neuroblastoma , genetics
Parkinson's disease (PD) is characterized by the selective loss of dopaminergic neurons in the substantia nigra (SN), and it has been suggested that dopamine is one of the main endogenous toxins in the genesis of PD. We demonstrated that thiol antioxidants (the reduced form of glutathione, N ‐acetyl‐L‐cysteine, and L‐cysteine), which conjugate with one dopamine oxidation intermediate, o ‐quinone, provided almost complete protection from dopamine‐mediated toxicity in SH‐SY5Y, a human neuroblastoma cell line. In contrast, catalase partially provided protection against cell death caused by dopamine. These data suggest that the generation of dopamine oxidation intermediates, rather than hydrogen peroxide, plays a pivotal role in dopamine‐induced toxicity. Iron accumulated in the SN of patients with PD can cause dopaminergic neuronal degeneration by enhancing oxidative stress. However, we found that iron reduced the total amounts of dopamine oxidation intermediates and enhanced the formation of melanin, a final product of dopamine oxidation. Also, addition of iron inhibited dopamine‐induced cytotoxicity. These results suggest that iron can provide protection when it accelerates the conversion of dopamine oxidation intermediates. © 2005 Wiley‐Liss, Inc.